Results 91 to 100 of about 654,709 (293)
Cancer‐associated fibroblasts (CAFs) promote cancer growth, invasion (metastasis), and drug resistance. Here, we identified functional and diverse circulating CAFs (cCAFs) in patients with metastatic prostate cancer (mPCa). cCAFs were found in higher numbers and were functional and diverse in mPCa patients versus healthy individuals, suggesting their ...
Richell Booijink+6 more
wiley +1 more source
Seminars in Proactive Artificial Intelligence for Cybersecurity (SPAIC): Consulting and Research [PDF]
The authors have designed a platform for research and consulting through a high-level collaborative seminar series to promote networking in proactive artificial intelligence (AI) for cybersecurity (SPAIC).
Ehsan Sheybani, Giti Javidi
doaj
Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells
In the era of immunotherapies, many patients either do not respond or eventually develop resistance. We propose to pave the way for proteomic analysis of surface‐expressed proteins called surfaceome, of circulating tumor cells. This approach seeks to identify immune evasion mechanisms and discover potential therapeutic targets. Circulating tumor cells (
Doryan Masmoudi+3 more
wiley +1 more source
Circulating tumor DNA (ctDNA) offers a possibility for different applications in early and late stage breast cancer management. In early breast cancer tumor informed approaches are increasingly used for detecting molecular residual disease (MRD) and early recurrence. In advanced stage, ctDNA provides a possibility for monitoring disease progression and
Eva Valentina Klocker+14 more
wiley +1 more source
In this explorative biomarker analysis, we assessed serial sampling of circulating tumor cells (CTCs) with CellSearch in two randomized trials testing immune checkpoint inhibitors (ICIs) in metastatic breast cancer. Our data demonstrate a prognostic potential of CTCs, most apparent 4 weeks into ICI therapy.
Nikolai Kragøe Andresen+13 more
wiley +1 more source
Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha+6 more
wiley +1 more source
El texto da a conocer la estructuración de resúmenes de artículos científicos publicados basado en una línea de investigación en discurso académico de la educación, para ser más específico con géneros textuales relevantes de este ámbito.
Carlos Eduardo Blanco+1 more
doaj
Ethics Pathways: A Design Activity for Reflecting on Ethics Engagement in HCI Research [PDF]
This paper introduces Ethics Pathways, a design activity aimed at understanding HCI and design researchers' ethics engagements and flows during their research process. Despite a strong ethical commitment in these fields, challenges persist in grasping the complexity of researchers' engagement with ethics -- practices conducted to operationalize ethics -
arxiv +1 more source
Closure to “Discussions of ‘Modern Steam Passenger Locomotives—Research and Design’” (1942, Trans. ASME, 64, pp. 13–17) [PDF]
P. W. Kiefer
openalex +1 more source
A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini+11 more
wiley +1 more source